Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus
- 1 December 1998
- journal article
- Published by Elsevier in Metabolism
- Vol. 47 (12) , 1481-1489
- https://doi.org/10.1016/s0026-0495(98)90074-9
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetesDiabetes, 1996
- Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitusDiabetes Research and Clinical Practice, 1995
- The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitusJournal of Clinical Endocrinology & Metabolism, 1994
- Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type AActa Endocrinologica, 1994
- Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitusJournal of Clinical Endocrinology & Metabolism, 1993
- The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1993
- Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromesDiabetes, 1993
- Abnormal Regulation of Insulin-Like Growth Factor Binding Proteins in Adolescents with Insulin-Dependent Diabetes*Journal of Clinical Endocrinology & Metabolism, 1991
- Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistanceDiabetologia, 1991
- Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetesDiabetes, 1984